Statistics from Altmetric.com
The following information has been produced for Veterinary Record by the Veterinary Medicines Directorate (VMD) to provide an update for veterinary surgeons on recent changes to marketing authorisations for veterinary medicines in the UK.
This summary forms part of a continuing series of monthly updates for Veterinary Record from the Veterinary Medicines Directorate. The last summary was published in VR, Sept 30, 2017, vol 181, pp 338-340.
The points below highlight changes in marketing authorisations that may have a significant impact on veterinary surgeons’ prescribing decisions.
New marketing authorisations
New marketing authorisations relevant to veterinary surgeons in the UK that were issued and/or published in August 2017 are listed in Table 1.
Of the products listed, the VMD draws attention to the following products:
Dormazolam 5 mg/ml solution for injection for horses contains midazolam, a new active substance authorised for use in horses. The product is indicated for intravenous co-induction of anaesthesia with ketamine for …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.